John Tan is the founder of Synthego. Synthego has raised $250M in total funding. Latest round: Series D.
John Tan is the Chief Operating Officer of Synthego, a genome engineering company. Synthego raised $100 million in a Series D financing, bringing its total private funding to more than $250 million. The company's platforms produce standardized CRISPR reagents and engineered cells for rapid discovery, validation, and genetic pathway analysis.
Full founder directory · Investor directory · Company funding database · Fundraising library